Devices › Device types
FDA product code MBB · class 2 · Orthopedic
Bone cement, antibiotic: medical device reports filed with FDA
3,709 reports carry this product code, 1992–2026; 12 brands with a page.
- 3,709
- reports with this product code
- 0% of all MAUDE reports
- 182
- reports, 12 months to August 2026
- 189 in the 12 months before
- 47.6%
- classified as malfunction
- 62.3% across all reports
- 1.3%
- classified as death, as reported
- 0.9% across all reports
Product code MBB is FDA's classification for "Bone cement, antibiotic" (orthopedic panel), a class 2 device. 3,709 medical device reports carry this product code, 0% of the MAUDE database, from January 1992 to August 2026.
182 reports arrived in the 12 months to August 2026, close to the 189 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (51.1%), malfunction (47.6%) and death (1.3%). 12 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Smartset Gmv 40g Us Eo | 752 | 40 | 0% | 6.2% |
| Smartset Ghv Gentamicin 40g | 576 | 40 | 0.4% | 17.3% |
| Refobacin Bone Cement R 1x40g | 242 | 0 | 1.2% | 95.9% |
| Depuy/Cmw 2g | 140 | 4 | 0.6% | 4.3% |
| Depuy1 Gentamicin Cement 40g | 135 | 0 | 0.7% | 1.9% |
| Smartset Hv Bone Cement 40g | 12 | 3 | 0% | 8.1% |
| Simplex P-Japanese Twin Pack | 4 | 1 | 10.6% | 71.5% |
| Smartset Mv 40g - Eo | 4 | 4 | 0.1% | 6.2% |
| Unknown Bone Cement | 4 | 37 | 0% | 3.8% |
| Smartset Mv Endurance 80g | 2 | 1 | 0% | 0.6% |
| Mbt Cem Keel Tib Tray Sz3 | 1 | 9 | 0% | 0.6% |
| Mbt Cem Keel Tib Tray Sz5 | 1 | 3 | 0% | 1.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Biomet France R L | 1,563 | 42.1% |
| Depuy Cmw - 9610921 | 767 | 20.7% |
| Depuy Cmw | 94 | 2.5% |
| Depuy Cmw 9610921 | 51 | 1.4% |
| Zimmer Surgical | 29 | 0.8% |
| Depuy Orthopaedics US 1818910 | 7 | 0.2% |
| Depuy Orthopaedics 1818910 | 4 | 0.1% |
| Depuy Orthopaedics | 2 | 0.1% |
| Biomet | 1 | 0% |
| Depuy France | 1 | 0% |
| Depuy Ireland | 1 | 0% |
| Howmedica Osteonics | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Loss of or failure to bond | 1,103 | 29.7% |
| Unsealed device packaging | 713 | 19.2% |
| Infusion or flow problema problem with flow or infusion | 339 | 9.1% |
| Chemical problem | 216 | 5.8% |
| Improper chemical reaction | 149 | 4% |
| Insufficient device problem information | 105 | 2.8% |
| Loosening of implant not related to bone-ingrowth | 101 | 2.7% |
| Tear, rip or hole in device packaging | 63 | 1.7% |
| Device damaged prior to usethe device was damaged before use | 55 | 1.5% |
| Device contaminated during manufacture or shipping | 54 | 1.5% |
| No flow | 53 | 1.4% |
| Patient device interaction problem | 46 | 1.2% |
| Migrationthe device moved from where it was placed | 32 | 0.9% |
| Device damaged prior to receipt by user | 30 | 0.8% |
| Difficult to open or remove packaging material | 25 | 0.7% |
| Loss of osseointegration | 24 | 0.6% |
| Device packaging compromised | 21 | 0.6% |
| Device dislodged or dislocated | 17 | 0.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 12 | 0.3% |
| Material integrity problema problem with the device material | 12 | 0.3% |
Questions about bone cement, antibiotic reports
What is product code MBB?
FDA's classification code for "Bone cement, antibiotic", class 2, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,709 reports through August 2026, 182 of them in the latest 12 months.
Which brands appear most often?
Smartset Gmv 40g Us Eo (752), Smartset Ghv Gentamicin 40g (576), Refobacin Bone Cement R 1x40g (242), Depuy/Cmw 2g (140) and Depuy1 Gentamicin Cement 40g (135). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.